Chongqing Genrix Biopharmaceutical Co., Ltd.

SSE
688443
Stock
Yield per half year: -7.39%
Dividend yield: 0%
Sector: Нефтегаз

Reporting Chongqing Genrix Biopharmaceutical Co., Ltd.

Capitalization

IFRS
Reporting Annual
5 year average CAGR 5


Share

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM 5 year average CAGR 5
Цена акции ао 39.95 25.09 28.44 28.44 31.16 -10.71


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROS, % 0 0 0 0
ROCE, % 0 0
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0
Operation Margin, % 0 0 0 0


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/FCF
0 0 0 0
E/P
0 0 0 0
EV/EBIT
0 0 0
EV/S
0 0 0 0
EV/FCF
0 0 0
Debt/EBITDA
0 0 0 0
Netdebt/Ebitda
0 0 0 0
Debt/Ratio
0 0 0 0
Debt/Equity
0 0 0 0
Debt/Net Income
0 0 0 0
PEG
0 0
Бета
-5.7 -0.2939 1.46 1.46 -1.5113 -163.51
Индекс Альтмана
0 0 0 0


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe